Serial Markers of Bone Turnover in Men with Metastatic Prostate Cancer Treated with Zoledronic Acid for Detection of Bone Metastases Progression

Cancer Statistics, 2006

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Fred Saad, Donald M. Gleason, Robin Murray et al. · JNCI Journal of the National Cancer Institute · 2002 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

F. Saad, D. M. Gleason, R. Murray et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +14

Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

J.L. Hayward, Paul P. Carbone, S Kumaoka et al. · Cancer · 1977 · 627 citations · Full text

Medicine, Oncology, Breast Oncology +15

Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors

J. E. Brown, Richard J. Cook, Pierre Major et al. · JNCI Journal of the National Cancer Institute · 2005 · 564 citations · Full text

Medicine, Biostatistics, Oncology +16